Mira Pharmaceuticals MIRA Ratios (2022-2026)

NASDAQ MIRA
$0.62 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Mira Pharmaceuticals Quarterly Ratios

Periods 16 quarters
Latest Jun 2026

Mira Pharmaceuticals reported a net margin of -3,440.18% for the quarter ended Jun 2026. These financial ratios cover 16 quarters of results from Sep 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Net Margin -3,407.19%-4,293.03%-5,413.93%-6,297.59%-8,327.24%-17,832.68%-18,054.92%-2,774.68%-2,672.07%-3,440.18%
FCF Margin -2,081.75%-2,192.88%-4,879.51%-4,736.99%-7,609.48%-9,273.47%-872.70%-544.13%-2,674.93%-3,431.79%
Efficiency
Assets AverageAssets Avg. 6.42M6.98M4.37M3.41M3.64M3.59M2.16M1.13M4.25M9.36M10.28M8.83M
Equity AverageEquity Avg. 0.70M-0.14M-1.19M-0.30M4.66M6.24M3.77M2.69M2.90M2.89M1.75M0.93M4.06M8.97M9.87M8.76M
Invested CapitalInvested Cap. -0.46M3.00M2.24M
Asset Utilization RatioAsset Util. -0.12-0.60-0.94-1.11-0.910.050.060.090.050.040.040.05
Leverage & Solvency
Debt Ratio 0.160.470.01
Valuation
Price to SalesP/S 113.96120.56198.64135.2396.34113.8794.74
Price to BookP/B 8.474.466.874.265.928.5812.7336.913.473.444.814.89
Enterprise Value 62.86M14.89M18.15M6.64M17.00M16.05M15.27M20.31M18.68M24.75M35.56M31.82M
Market Capitalization 68.73M19.49M21.68M9.46M21.15M18.88M16.48M21.04M26.21M35.78M44.96M39.92M

Mira Pharmaceuticals Ratios API

Pull Mira Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MIRA&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY